sulpiride has been researched along with Vomiting in 18 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| " She developed these symptoms after having been administered parenteral levosulpiride to control vomiting due to secondary adrenal insufficiency." | 7.88 | Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritis. ( Biswas, A; Desai, D; Gupta, K; Kumar, R, 2018) |
| "The antiemetic activity, gastric motor activity, and dopamine receptor effects of metoclopramide, dazopride, and sulpiride were assessed to establish if enhancement of gastric motility or antagonism of central dopamine receptors is the predominant action for drug-induced suppression of cisplatin-induced emesis." | 7.67 | Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility. ( Alphin, RS; Dannenburg, WN; Johnson, DN; Kinnier, WJ; Leonard, CA; Proakis, AG; Sancilio, LF; Smith, WL; Ward, JW, 1986) |
| " We designed a comparative controlled study of Sulpiride and Domperidone, against nausea and vomiting during cancer chemotherapy." | 7.67 | [Clinical evaluation of sulpiride against nausea and vomiting during cancer chemotherapy compared with domperidone--envelope method]. ( Kawakami, K; Kawatsu, S; Komatsu, Y; Okamoto, K; Sakata, Y; Satoh, T; Suzuki, H; Takagi, S; Tanabe, K; Yoshida, Y, 1986) |
| " Both these doses have been effective in reducing the episodes of vomiting other than in preventing nausea and retching if considered versus controls and also versus droperidol at the doses of 5 mg (50 mg L-sul = 12%, 100 mg = 4%, droperidol = 20%, controls = 28%)." | 5.06 | [Antiemetic effect of the levo isomer of sulpiride (L-sulpiride) in humans]. ( Florio, T; Forgione, A; Lombardi, G; Mastronardi, P; Mazzarella, B; Merola, B; Pinto, M; Savastano, S; Scanni, E; Schettini, G, 1989) |
| " She developed these symptoms after having been administered parenteral levosulpiride to control vomiting due to secondary adrenal insufficiency." | 3.88 | Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritis. ( Biswas, A; Desai, D; Gupta, K; Kumar, R, 2018) |
| "The value of administering 25 mg of levosulpiride per os approximately one hour before the sodium fluorescein bolus used in fluorangiography is assessed in order to avoid to the onset of nausea and/or vomiting during and after the test." | 3.68 | [The clinical use of levosulpiride in retinal fluorangiography]. ( Bianchetti, L; Fusi, L; Paneghel, D; Rosina, A; Torrero, M; Vanzetti, M, 1990) |
| "The antiemetic activity, gastric motor activity, and dopamine receptor effects of metoclopramide, dazopride, and sulpiride were assessed to establish if enhancement of gastric motility or antagonism of central dopamine receptors is the predominant action for drug-induced suppression of cisplatin-induced emesis." | 3.67 | Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility. ( Alphin, RS; Dannenburg, WN; Johnson, DN; Kinnier, WJ; Leonard, CA; Proakis, AG; Sancilio, LF; Smith, WL; Ward, JW, 1986) |
| " We designed a comparative controlled study of Sulpiride and Domperidone, against nausea and vomiting during cancer chemotherapy." | 3.67 | [Clinical evaluation of sulpiride against nausea and vomiting during cancer chemotherapy compared with domperidone--envelope method]. ( Kawakami, K; Kawatsu, S; Komatsu, Y; Okamoto, K; Sakata, Y; Satoh, T; Suzuki, H; Takagi, S; Tanabe, K; Yoshida, Y, 1986) |
| "A new benzamide, cis-N-(1-benzyl-2-methylpyrrolidin - 3 - yl) - 5 - chloro - 2 - methoxy - 4 - methylaminobenzamide (YM-09151-2) exhibited more potent and longer-lasting inhibitory effects on apomorphine-induced behaviours (stereotyped behaviour, emesis and hypothermia), and methamphetamine-induced stereotyped behaviour, conditioned avoidance response and open field behaviour, conditioned avoidance response and open field behaviour than either structurally similar benzamides (YM-0850 and sulpiride) or classical neuroleptics [chlorpromazine (CPZ) and haloperidol(HPD)]." | 3.66 | Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity. ( Maeno, H; Nishikori, K; Noshiro, O; Usuda, S, 1981) |
| "The effect against nausea is of particular interest." | 2.87 | Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study. ( Christensen, TB; Daugaard, G; Fox, GM; Herrstedt, J; Holmskov, K; Molassiotis, A; Summers, Y; Taylor, PD, 2018) |
| "Levo-sulpiride is a substituted benzamide with antiemetic activity 3-8 times more potent than the racemic form and the d-isomer." | 2.38 | [Antiemetic properties of levo-sulpiride]. ( Guslandi, M, 1990) |
| " Thus, the inhibitory dose-response effects of a D2-preferring [sulpride], a D3-preferring [U 99194A] and combination of varying doses of these antagonists [sulpride + U 99194A] were evaluated on the ability of the cited agonists to produce vomiting." | 1.30 | The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew). ( Ahmad, B; Darmani, NA; Zhao, W, 1999) |
| "Severe vomiting was evoked by Apo in dogs, but not by Eph even when lethal dose (20 mg." | 1.28 | [Comparison of central stimulating effects between ephedrine and apomorphine]. ( Li, BH; Li, Q, 1991) |
| "Remoxipride was shown to be a selective dopamine D2 receptor antagonist since it displaced [3H]spiperone (IC50 = 1570 nM) but not [3H]flupentixol (IC50 greater than 100 000 nM) in rat striatum, and did not inhibit striatal DA-sensitive adenylate cyclase in vitro (IC50 greater than 100 000 nM)." | 1.27 | Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. ( Angeby, K; Florvall, L; Hall, H; Köhler, C; Lindbom, LO; Magnusson, O; Ogren, SO, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (50.00) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Yan, XJ | 1 |
| Xu, P | 1 |
| Qiu, HY | 1 |
| Wang, B | 1 |
| Luo, QQ | 1 |
| Chen, SL | 1 |
| Herrstedt, J | 1 |
| Summers, Y | 1 |
| Daugaard, G | 1 |
| Christensen, TB | 1 |
| Holmskov, K | 1 |
| Taylor, PD | 1 |
| Fox, GM | 1 |
| Molassiotis, A | 1 |
| Desai, D | 1 |
| Gupta, K | 1 |
| Kumar, R | 1 |
| Biswas, A | 1 |
| Henry, A | 1 |
| Charpiat, B | 1 |
| Vial, T | 1 |
| Franchini, S | 1 |
| Cuilleret, FJ | 1 |
| Milon, H | 1 |
| Usuda, S | 1 |
| Nishikori, K | 1 |
| Noshiro, O | 1 |
| Maeno, H | 1 |
| Ogren, SO | 1 |
| Hall, H | 1 |
| Köhler, C | 1 |
| Magnusson, O | 1 |
| Lindbom, LO | 1 |
| Angeby, K | 1 |
| Florvall, L | 1 |
| Cohen, N | 1 |
| Alon, I | 1 |
| Almoznino-Sarfian, D | 1 |
| Gorelik, O | 1 |
| Chachasvili, S | 1 |
| Litvinjuk, V | 1 |
| Modai, D | 1 |
| Weissgarten, J | 1 |
| Darmani, NA | 1 |
| Zhao, W | 1 |
| Ahmad, B | 1 |
| Corsini, GU | 1 |
| Zompo, MD | 1 |
| Cianchetti, C | 1 |
| Mangoni, A | 1 |
| Li, Q | 1 |
| Li, BH | 1 |
| Torrero, M | 1 |
| Rosina, A | 1 |
| Paneghel, D | 1 |
| Bianchetti, L | 1 |
| Fusi, L | 1 |
| Vanzetti, M | 1 |
| Guslandi, M | 1 |
| Schettini, G | 1 |
| Mastronardi, P | 1 |
| Scanni, E | 1 |
| Pinto, M | 1 |
| Forgione, A | 1 |
| Florio, T | 1 |
| Savastano, S | 1 |
| Merola, B | 1 |
| Lombardi, G | 1 |
| Mazzarella, B | 1 |
| Bianconcini, G | 1 |
| Mazzali, F | 1 |
| Morini, A | 1 |
| Gobbi, F | 1 |
| Rosenblatt, E | 1 |
| Lev, LM | 1 |
| Robinson, E | 1 |
| Alphin, RS | 1 |
| Proakis, AG | 1 |
| Leonard, CA | 1 |
| Smith, WL | 1 |
| Dannenburg, WN | 1 |
| Kinnier, WJ | 1 |
| Johnson, DN | 1 |
| Sancilio, LF | 1 |
| Ward, JW | 1 |
| Sakata, Y | 1 |
| Suzuki, H | 1 |
| Satoh, T | 1 |
| Kawatsu, S | 1 |
| Tanabe, K | 1 |
| Okamoto, K | 1 |
| Takagi, S | 1 |
| Komatsu, Y | 1 |
| Kawakami, K | 1 |
| Yoshida, Y | 1 |
| Decio, B | 1 |
| Libutti, M | 1 |
| Allaria, B | 1 |
| Picozzi, G | 1 |
1 review available for sulpiride and Vomiting
| Article | Year |
|---|---|
[Antiemetic properties of levo-sulpiride].
Topics: Chemical Phenomena; Chemistry; Gastrointestinal Diseases; Humans; Nausea; Postoperative Complication | 1990 |
5 trials available for sulpiride and Vomiting
| Article | Year |
|---|---|
Antiemetics improve the tolerance of polyethylene glycol for colonoscopy preparation: A randomized clinical trial.
Topics: Adult; Aged; Antiemetics; Cathartics; Colon; Colonoscopy; Domperidone; Female; Humans; Incidence; In | 2021 |
Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study.
Topics: Adult; Aged; Amisulpride; Antiemetics; Cisplatin; Dopamine Antagonists; Female; Humans; Male; Middle | 2018 |
Sulpiride versus metoclopramide in nononcologic patients with vomiting or nausea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Dose-Response Relationship, Drug; Double-Bl | 1999 |
[Antiemetic effect of the levo isomer of sulpiride (L-sulpiride) in humans].
Topics: Adolescent; Adult; Anesthesia, General; Antiemetics; Droperidol; Drug Administration Schedule; Femal | 1989 |
High-dose dexamethasone and high-dose metoclopramide versus high-dose dexamethasone and sulpiride in the management of cisplatin-induced emesis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dexamethasone; | 1988 |
12 other studies available for sulpiride and Vomiting
| Article | Year |
|---|---|
Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritis.
Topics: Adrenal Insufficiency; Antiemetics; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Humans; | 2018 |
Pheochromocytoma unmasked by amisulpride and tiapride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Calcium Channel Blockers; Headache; Humans; Hypertension; | 2005 |
Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Chlorpropamide; Dogs; Drug Evaluation, Precl | 1981 |
Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Binding | 1984 |
The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew).
Topics: Analysis of Variance; Animals; Apomorphine; Benzopyrans; Brain Chemistry; Disease Models, Animal; Do | 1999 |
Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in Parkinsonism.
Topics: Adult; Apomorphine; Drug Therapy, Combination; Haloperidol; Humans; Male; Metoclopramide; Parkinson | 1976 |
[Comparison of central stimulating effects between ephedrine and apomorphine].
Topics: Animals; Apomorphine; Blepharoptosis; Catalepsy; Ephedrine; Haloperidol; Male; Mice; Motor Activity; | 1991 |
[The clinical use of levosulpiride in retinal fluorangiography].
Topics: Adult; Aged; Fluorescein; Fluorescein Angiography; Fluoresceins; Humans; Middle Aged; Nausea; Radiog | 1990 |
[Antiemetic protocol in oncohematologic polychemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chlorph | 1988 |
Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility.
Topics: Animals; Benzamides; Cisplatin; Dogs; Dose-Response Relationship, Drug; Female; Gastrointestinal Mot | 1986 |
[Clinical evaluation of sulpiride against nausea and vomiting during cancer chemotherapy compared with domperidone--envelope method].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Domperidone; Drug Evaluation; Female; H | 1986 |
[Prevention of postoperative vomiting with sulpiride].
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Postoperative Complications; Sulpiride; | 1973 |